Skip to content
memoinOncology Logo memoinOncology Logo memoinOncology Logo
  • CONGRESS REPORTS
    • Solid Tumors
      • ASCO
      • EANM
      • ESMO
      • ESMO IO
    • Hematology
      • ASH
      • EHA
      • ESH CLL
      • ISHL
      • iwWM
    • Lung Cancer
      • ASCO
      • CSCO
      • ECC
      • ELCC
      • ESMO
      • ESMO Asia
      • WCLC
  • MEDICAL EDUCATION
    • Clinical Trials
    • Preceptorship reports
    • Articles
  • COLLABORATIONS
    • CSCO
    • LACOG
    • SEO
    • SSO
  • SUPPORTER
    • Boehringer Ingelheim in Oncology
    • BeiGene
    • ITM
  • MORE…
    • ABOUT US
    • LINKS
    • CALENDAR
    • VIDEOS

Intracranial activity of ceritinib in crizotinib-pretreated and crizotinib-naïve ALK-positive NSCLC patients

Intracranial activity of ceritinib in crizotinib

Read More

Immunotherapy: management of toxicity

Immunotherapy: management of toxicity The ba

Read More

PD-L1 expression is a nightmare in terms of complexity

PD-L1 expression is a nightmare in terms of comp

Read More

Immunotherapy: anti-tumour activity despite extensive pretreatment

Immunotherapy: anti-tumour activity despite exte

Read More

Risks and chances in patients with oligometastatic disease

Risks and chances in patients with oligometastat

Read More

Disease progression on EGFR TKI therapy: what to do after erlotinib, gefitinib and afatinib?

Disease progression on EGFR TKI therapy: what to

Read More

EGFR-mutation-positive NSCLC: expanding the data pool for established treatment options

EGFR-mutation-positive NSCLC: expanding the data

Read More

Preface – ESMO Asia 2015

Preface – ESMO Asia 2015 Frances A. Shepherd

Read More

Sponsors:
This website is intended only for healthcare professionals outside the US, the UK, and Australia   |   This website is supported by an unrestricted medical education grant from BeiGene, Boehringer Ingelheim and ITM
© Copyright 2012 -  memoinOncology BY SPRINGER-VERLAG GmbH   |   Projekt: infill healthcare communication GmbH.   |   Alle Rechte vorbehalten.   |   Die Nutzung der Inhalte ist ausschließlich für den privaten Gebrauch bestimmt. Die über den persönlichen Gebrauch hinausgehende Vervielfältigung und Verbreitung ist nicht gestattet.
Impressum   |   Datenschutzerklärung   |   AGB   |   Kontakt   |   Cookie Einstellungen

Accessibility by WAH